EcoDrugPlus

Oxytocin Receptor

Ensembl ID : ENSDORG00000007711
Gene Symbol: OXTR
3 Cross references
265 Possible Orthologues:

P21 (Rac1) Activated Kinase 4

Ensembl ID : ENSDORG00000006722
Gene Symbol: PAK4
4 Cross references
160 Possible Orthologues:

Pancreatic Triacylglycerol Lipase

Ensembl ID : ENSDORG00000026695
Gene Symbol: LOC105986718
3 Cross references
292 Possible Orthologues:

Pancreatic Triacylglycerol Lipase-Like

Ensembl ID : ENSDORG00000027066
Gene Symbol: LOC105986719
3 Cross references
280 Possible Orthologues:

Parathyroid Hormone 1 Receptor

Ensembl ID : ENSDORG00000015600
Gene Symbol: PTH1R
3 Cross references
199 Possible Orthologues:

Peptidylprolyl Isomerase A

Ensembl ID : ENSDORG00000028871
Gene Symbol: PPIA
2 Cross references
316 Possible Orthologues:

Peroxisome Proliferator Activated Receptor Alpha

Ensembl ID : ENSDORG00000003547
Gene Symbol: PPARA
4 Cross references
455 Possible Orthologues:

Peroxisome Proliferator Activated Receptor Delta

Ensembl ID : ENSDORG00000009154
Gene Symbol: PPARD
4 Cross references
420 Possible Orthologues:

Peroxisome Proliferator Activated Receptor Gamma

Ensembl ID : ENSDORG00000003445
Gene Symbol: PPARG
4 Cross references
407 Possible Orthologues:

Phosphatidylinositol 4,5-Bisphosphate 3-Kinase Catalytic Subunit Delta Isoform-Like

Ensembl ID : ENSDORG00000028237
Gene Symbol: LOC106000559
2 Cross references
213 Possible Orthologues:

Phosphatidylinositol-4,5-Bisphosphate 3-Kinase Catalytic Subunit Alpha

Ensembl ID : ENSDORG00000009553
Gene Symbol: PIK3CA
4 Cross references
273 Possible Orthologues:

Phosphatidylinositol-4,5-Bisphosphate 3-Kinase Catalytic Subunit Beta

Ensembl ID : ENSDORG00000006339
Gene Symbol: PIK3CB
3 Cross references
217 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).